Financial News

Aimmune Therapeu Down 21.3% Since SmarTrend Downtrend Call (AIMT)

SmarTrend identified a Downtrend for Aimmune Therapeu (NASDAQ:AIMT) on February 21st, 2018 at $33.22. In approximately 7 months, Aimmune Therapeu has returned 21.31% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback